None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: a) the presence of an unresectable malignant distal biliary obstruction (greater than 2 cm distal to the hilum); b) failed conventional ERCP and inaccessible papilla because of accompanying duodenal obstruction, periampullary tumor infiltration, or surgically altered anatomy; c) histologic or cytologic diagnosis of malignancy; d) a Karnofsky index of ?30%; e) no serious or uncontrolled medical illnesses; and f) provision of informed consent.
Exclusion criteria
Exclusion criteria: a) patient age of less than 18 years, b) hilar biliary obstruction, c) uncorrectable coagulopathy, d) a history of allergies to radiocontrast agents, and e) refusal to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Technical success of EUS-BD and PTBD | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life, Complications- bleeding, perforation, peritonitis, etc. | — |
Countries
Korea, Republic of
Contacts
Soon Chun Hyang University Hospital Cheonan